Showing results (171-180 of 361) with videos related to

Sort By:
Pageof 37
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's diseasePrzemysław R Kac, Daniel Alcolea, Laia Montoliu-Gaya, et al.
Annals of Clinical and Translational Neurology|December 3, 2019
APP-derived peptides reflect neurodegeneration in frontotemporal dementiaIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.
Neurology|October 16, 2015
Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter studyMarissa D Zwan, Juha O Rinne, Steen G Hasselbalch, et al.
Arquivos De Neuro-Psiquiatria|May 31, 2023
Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [18F]FDG-PET/MRI studyMateus Rozalem Aranha, Artur Martins Coutinho, Camila de Godoi Carneiro, et al.
Neuropathology and Applied Neurobiology|January 26, 2023
Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's diseasePaula Ferrer-Raventós, David Puertollano-Martín, Marta Querol-Vilaseca, et al.
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.
Lancet (London, England)|September 25, 2025
New landscape of the diagnosis of Alzheimer's diseaseGiovanni B Frisoni, Oskar Hansson, Emma Nichols, et al.
Oncotarget|September 24, 2015
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controlsFrederic Sampedro, Eduard Vilaplana, Mony J de Leon, et al.
Alzheimer'S Research & Therapy|July 5, 2025
Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinicJavier Arranz, Rosa Ferrer, Nuole Zhu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's diseasePrzemysław R Kac, Daniel Alcolea, Laia Montoliu-Gaya, et al.
Pageof 37